Irregularity Indices for Certain Anti-Tumor and Anti-Covid Drugs

References

• Alan R. Katritzky, Ritu Jain, Andre Lomaka, Ruslan Petrukhin, Uko Maran, and Mati Karelson, “Perspective on the Relationship between Melting Points and Chemical Structure,” Crystal Growth & Design 1, no. 4 (2001): 261–5.
   Web of Science ®Google Scholar
• Alan R. Katritzky, Lan Mu, Victor S. Lobanov, and Mati Karelson, “Correlation of Boiling Points with Molecular Structure. 1. A Training Set of 298 Diverse Organics and a Test Set of 9 Simple Inorganics,” The Journal of Physical Chemistry 100, no. 24 (1996): 10400–7.
   Web of Science ®Google Scholar
• Harry Wiener, “Structural Determination of Paraffin Boiling Points,” Journal of the American Chemical Society 69, no. 1 (1947): 17–20.
   PubMed Web of Science ®Google Scholar
• Lina Zheng, Yiqiao Wang, and Wei Gao, “Topological Indices of Hyaluronic Acid-Paclitaxel Conjugates’ Molecular Structure in Cancer Treatment,”Open Chemistry 17, no. 1 (2019): 81–7.
   Web of Science ®Google Scholar
• Abdul Rauf, Muhammad Ishtiaq, Muhammad Kamran Siddiqui, and Rimsha Andleeb, “Topological Properties of Doxorubicin Conjugated PEG-PAsp Copolymer Molecular Structure Used in Cancer Treatment,” Polycyclic Aromatic Compounds (2020): 1–14.
   Web of Science ®Google Scholar
• Ramón García-Domenech, Jorge Gálvez, Jesus V. de Julián-Ortiz, and Lionello. Pogliani, “Some New Trends in Chemical Graph Theory,”Chemical Reviews 108, no. 3 (2008): 1127–69. no.
   PubMed Web of Science ®Google Scholar
• Danail Bonchev. Information Theoretic Indices for Characterization of Chemical Structures, Vol. 5. (New York: Research Studies Press, 1983).
   Google Scholar
• Zehui Shao, Pu Wu, Xiujun Zhang, Darko Dimitrov, and Jia-Bao Liu, “On the Maximum ABC Index of Graphs with Prescribed Size and without Pendent Vertices,” IEEE Access. 6 (2018): 27604–16.
   Web of Science ®Google Scholar
• Zehui Shao, Pu Wu, Yingying Gao, Ivan Gutman, and Xiujun Zhang, “On the Maximum ABC Index of Graphs without Pendent Vertices,” Applied Mathematics and Computation 315, (2017): 298–312.
   Web of Science ®Google Scholar
• Lothar Von Collatz, and Ulrich Sinogowitz, “Spektren Endlicher Grafen,” Abhandlungen Aus Dem Mathematischen Seminar Der Universität Hamburg 21, no. 1 (1957): 63–77.
   Google Scholar
• Paul L. Krapivsky, Sidney Redner, and Francois Leyvraz, “Connectivity of Growing Random Networks,” Physical Review Letters 85, no. 21 (2000): 4629–32.
   PubMed Web of Science ®Google Scholar
• Francis K. Bell, “A Note on the Irregularity of Graphs,” Linear Algebra and Its Applications 161 (1992): 45–54.
   Web of Science ®Google Scholar
• Ivan Gutman, “Irregularity of Molecular Graphs,” Kragujevac Journal of Science 38, no. 38 (2016): 71–81.
   Google Scholar
• Michael O. Albertson, “The Irregularity of a Graph,” Ars Combinatoria 46 (1997): 219–25.
   Web of Science ®Google Scholar
• Darko Dimitrov, and Tamás Réti, “Graphs with Equal Irregularity Indices,” Acta Polytech. Hung 11, no. 4 (2014): 41–57.
   Web of Science ®Google Scholar
• Jialin Zheng, Shehnaz Akhter, Zahid Iqbal, Muhammad Kashif Shafiq, Adnan Aslam, Muhammad Ishaq, and Muhammad Aamir, “Irregularity Measures of Subdivision Vertex-Edge Join of Graphs,” Journal of Chemistry 2021 (2021): 1–12.
   Web of Science ®Google Scholar
• Tamas Réti, and Reza Sharafdini, “Agota Dregelyi-Kiss, and Hossein Haghbin.” “Graph Irregularity Indices Used as Molecular Descriptors in QSPR Studies,” MATCH Communications in Mathematical and in Computer Chemistry 79 (2018): 509–24.
   Web of Science ®Google Scholar
• Ernesto Estrada, “Randic Index, Irregularity and Complex Biomolecular Networks,” Acta Chimica Slovenica 57, no. 3 (2010): 597–603.
   PubMed Web of Science ®Google Scholar
• Ivan Gutman, Pierre Hansen, and Hadrien Mélot, “Variable Neighborhood Search for Extremal Graphs. 10. Comparison of Irregularity Indices for Chemical Trees,” Journal of Chemical Information and Modeling 45, no. 2 (2005): 222–30.
   PubMed Web of Science ®Google Scholar
• G. H. Fath-Tabar, “Old and New Zagreb Indices of Graphs,” MATCH Communications in Mathematical and in Computer Chemistry 65, no. 1 (2011): 79–84.
   Web of Science ®Google Scholar
• Darko Dimitrov, “Hosam Abdo,” Theoretical Computer Science 16 (2014): 201–6.
   Google Scholar
• Darko Dimitrov, and Riste Škrekovski, “Comparing the Irregularity and the Total Irregularity of Graphs,” Ars Mathematica Contemporanea 9, no. 1 (2014): 45–50.
   Web of Science ®Google Scholar
• A. Hatefi, and B. Amsden, “Camptothecin Delivery Methods,” Pharmaceutical Research 19, no. 10 (2002): 1389–99.
   PubMed Web of Science ®Google Scholar
• Craig J. Thomas, Nicolas J. Rahier, and Sidney M. Hecht, “Camptothecin: current Perspectives,”Bioorganic & Medicinal Chemistry 12, no. 7 (2004): 1585–604.
   PubMed Web of Science ®Google Scholar
• Leroy F. Liu, Shyamal D. Desai, Tsai-Kun. Li, Yong Mao, M. E. I. Sun, and S. A. I.-P. E. N. G. Sim, “Mechanism of Action of Camptothecin,” Annals of the New York Academy of Sciences 922, no. 1 (2000): 1–10.
   PubMedGoogle Scholar
• Arthur G. Schultz, “Camptothecin,” Chemical Reviews 73, no. 4 (1973): 385–405.
   PubMed Web of Science ®Google Scholar
• Retia, Tamás, Reza Sharafdinib, Hossein Haghbinc, and Ágota Drégelyi-Kissa. “Graph irregularity indices used as molecular descriptors in QSAR/QSPR studies.” MATCH Commun. Math. Comput. Chem. 79 (2018): 509–524.
   Google Scholar
• Ozge Colakoglu Havare, “QSPR Analysis with Curvilinear Regression Modeling and Topological Indices,” Iranian Journal of Mathematical Chemistry 10, no. 4 (2019): 331–41.
   Web of Science ®Google Scholar
• Dongjie Yu, Ze. Zhuang, Jianhua Ren, Xuefeng Hu, Zhe Wang, Jieyu Zhang, Yuansen Luo, Kun Wang, Ronghan He, and Yunbing Wang, “Hyaluronic Acid-Curcumin Conjugate Suppresses the Fibrotic Functions of Myofibroblasts from Contractive Joint by the PTGER2 Demethylation,” Regenerative Biomaterials 6, no. 5 (2019): 269–77.
   PubMed Web of Science ®Google Scholar
• Wing-Hin Lee, Ching-Yee Loo, Mary Bebawy, Frederick Luk, Rebecca S. Mason, and Ramin Rohanizadeh, “Curcumin and Its Derivatives: their Application in Neuropharmacology and Neuroscience in the 21st Century,” Current Neuropharmacology 11, no. 4 (2013): 338–78.
   PubMed Web of Science ®Google Scholar
• Julia S. Dempe, Erika Pfeiffer, Anne S. Grimm, and Manfred Metzler, “Metabolism of Curcumin and Induction of Mitotic Catastrophe in Human Cancer Cells,” Molecular Nutrition & Food Research 52, no. 9 (2008): 1074–81.
   PubMed Web of Science ®Google Scholar
• Manfred Metzler, Erika Pfeiffer, Simone I. Schulz, and Julia S. Dempe, “Curcumin Uptake and Metabolism,” BioFactors (Oxford, England) 39, no. 1 (2013): 14–20.
   PubMed Web of Science ®Google Scholar
• Kavirayani Indira Priyadarsini, “The Chemistry of Curcumin: From Extraction to Therapeutic Agent,” Molecules (Basel, Switzerland) 19, no. 12 (2014): 20091–112.
   PubMed Web of Science ®Google Scholar
• Murali M. Yallapu, Prashanth K. Bhusetty Nagesh, Meena Jaggi, and Subhash C. Chauhan, “Therapeutic Applications of Curcumin Nanoformulations,” The AAPS Journal 17, no. 6 (2015): 1341–56.
   PubMed Web of Science ®Google Scholar
• Peters, Wallace, and William H. G. Richards, eds. Antimalarial Drug II: Current Antimalarial and New Drug Developments (Berlin Heidelberg: Springer, 1984).
   Google Scholar
• Jacob H. Rand, Xiao-Xuan Wu, Anthony S. Quinn, Pojen P. Chen, James J. Hathcock, and Douglas J. Taatjes, “Hydroxychloroquine Directly Reduces the Binding of Antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers,” Blood 112, no. 5 (2008): 1687–95.
   PubMed Web of Science ®Google Scholar
• Donald M. Pillsbury, and Coleman Jacobson, “Treatment of Chronic Discoid Lupus Erythematosus with Chloroquine (araten)),” Journal of the American Medical Association 154, no. 16 (1954): 1330–3.
   PubMed Web of Science ®Google Scholar
• Canadian Hydroxychloroquine Study Group, “A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus Erythematosus,” New England Journal of Medicine 324, no. 3 (1991): 150–4.
   PubMed Web of Science ®Google Scholar
• C. Neville Banks, “Melanin: blackguard or Red Herring? Another Look at Chloroquine Retinopathy,” Australian and New Zealand Journal of Ophthalmology 15, no. 4 (1987): 365–70.
   PubMedGoogle Scholar
• Leon Goldman, and Robert H. Preston, “Reactions to Chloroquine Observed during the Treatment of Various Dermatologic Disorders,” The American Journal of Tropical Medicine and Hygiene 6, no. 4 (1957): 654–7.
   PubMed Web of Science ®Google Scholar
• Edward L. Beard, Jr, “The American Society of Health System Pharmacists,” JONA’S Healthcare Law, Ethics and Regulation 3, no. 3 (2001): 78–9.
   PubMedGoogle Scholar
• Christopher Y. Chew, Adrian Mar, Mandana Nikpour, and Amanda M. Saracino, “Hydroxychloroquine in Dermatology: New Perspectives on an Old Drug,”The Australasian Journal of Dermatology 61, no. 2 (2020): e150–e157.
   PubMed Web of Science ®Google Scholar
• Shi-Qin Wang, Li-Wei Zhang, Pan Wei, and Hong Hua, “Is Hydroxychloroquine Effective in Treating Primary Sjogren’s Syndrome: A Systematic Review and Meta-Analysis,” BMC Musculoskeletal Disorders 18, no. 1 (2017): 1–13.
   PubMedGoogle Scholar
• Allen C. Steere, and Sheryn M. Angelis, “Therapy for Lyme Arthritis: strategies for the Treatment of Antibiotic-Refractory Arthritis,” Arthritis and Rheumatism 54, no. 10 (2006): 3079–86.
   PubMed Web of Science ®Google Scholar
• P. Seideman, and A. M. Ros, “Sensitivity to UV Light during Treatment with Chloroquine in Rheumatoid Arthritis,” Scandinavian Journal of Rheumatology 21, no. 5 (1992): 245–7.
   PubMed Web of Science ®Google Scholar
• Lo’ai Alanagreh, Foad Alzoughool, and Manar Atoum, “Risk of Using Hydroxychloroquine as a Treatment of COVID-19,” The International Journal of Risk & Safety in Medicine 31, no. 3 (2020): 111–6.
   PubMed Web of Science ®Google Scholar
• Salman Mardones, P. I. Quevedo Langenegger, M. Arias Thormann, C. Stehr Gesche, and A. Bancalari Selman, “Hypoglycemia Due to Hydroxychloroquine, an Uncommon Association but to Keep in Mind, Case Report and Review of Literature,” Journal of Diabetes, Metabolic Disorders & Control 7, no. 1 (2020): 6–7.
   Google Scholar
• Plaquenil (hydroxychloroquine) drug. https://www.rxlist.com/plaquenil-drug.htm
   Google Scholar
• Julie Marks, Hydroxychloroquine (Plaquenil), 2017. https://www.everydayhealth.com/drugs/hydroxychloroquine#drug-side-effects
   Google Scholar
• FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems, https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or
   Google Scholar
• Wesley H. Self, Matthew W. Semler, Lindsay M. Leither, Jonathan D. Casey, Derek C. Angus, Roy G. Brower, Steven Y. Chang, Sean P. Collins, John C. Eppensteiner, Michael R. Filbin, et al. “Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients with COVID-19: A Randomized Clinical Trial,”JAMA 324, no. 21 (2020): 2165–76.
   PubMed Web of Science ®Google Scholar